What is the retention period for cancer drug repository records?

The retention period for cancer drug repository records is established to ensure that there is a clear and accessible history of all transactions involving these drugs. In Minnesota, the law specifies that records related to the donation, dispensing, and inventory of cancer medications must be maintained for a minimum of five years. This period allows sufficient time for reviewing the records if any questions arise about a particular transaction, ensuring accountability and compliance with regulations.

Retaining records for five years provides a balance between accessibility for oversight and managing the burden of record-keeping in pharmacies. Knowledge of this duration is essential for pharmacy professionals, as it ensures they remain in compliance with state requirements while effectively managing their operational documentation practices.